P
PharmaResearch Co Ltd
KOSDAQ:214450
PharmaResearch Co Ltd
KOSDAQ:214450
Price:
257 500
KRW
1.58%
Market Closed
Market Cap:
2.7T
KRW
Add
Note
Why Create Notes?
Capture your thoughts
| US |
|
Johnson & Johnson
NYSE:JNJ
|
Pharmaceuticals
|
| US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
Financial Services
|
| US |
|
Bank of America Corp
NYSE:BAC
|
Banking
|
| US |
|
Mastercard Inc
NYSE:MA
|
Technology
|
| US |
|
UnitedHealth Group Inc
NYSE:UNH
|
Health Care
|
| US |
|
Exxon Mobil Corp
NYSE:XOM
|
Energy
|
| US |
|
Pfizer Inc
NYSE:PFE
|
Pharmaceuticals
|
| US |
|
Palantir Technologies Inc
NYSE:PLTR
|
Technology
|
| US |
|
Nike Inc
NYSE:NKE
|
Textiles, Apparel & Luxury Goods
|
| US |
|
Visa Inc
NYSE:V
|
Technology
|
| CN |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
Retail
|
| US |
|
3M Co
NYSE:MMM
|
Industrial Conglomerates
|
| US |
|
JPMorgan Chase & Co
NYSE:JPM
|
Banking
|
| US |
|
Coca-Cola Co
NYSE:KO
|
Beverages
|
| US |
|
Walmart Inc
NYSE:WMT
|
Retail
|
| US |
|
Verizon Communications Inc
NYSE:VZ
|
Telecommunication
|
If you don’t study any companies, you have the same success buying stocks as you do in a poker game if you bet without looking at your cards.
Peter Lynch
Track and Analyze Performance
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Continuous Learning and Adaptation
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
Boost Decision Confidence
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Delete Note
Do you really want to delete this note?
This action cannot be undone.
Alert
PharmaResearch Co Ltd
257500
+4000 (+1.58%)
| 52 Week Range |
89 100
259 500
|
| Price Target |
|
We'll email you a reminder when the closing price reaches KRW.
Choose the stock you wish to monitor with a price alert.
|
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
|
Bank of America Corp
NYSE:BAC
|
US |
|
|
Mastercard Inc
NYSE:MA
|
US |
|
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
|
Pfizer Inc
NYSE:PFE
|
US |
|
|
Palantir Technologies Inc
NYSE:PLTR
|
US |
|
|
Nike Inc
NYSE:NKE
|
US |
|
|
Visa Inc
NYSE:V
|
US |
|
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
|
3M Co
NYSE:MMM
|
US |
|
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
|
Coca-Cola Co
NYSE:KO
|
US |
|
|
Walmart Inc
NYSE:WMT
|
US |
|
|
Verizon Communications Inc
NYSE:VZ
|
US |
Delete Alert
This alert will be permanently deleted.
Ask me anything about
PharmaResearch Co Ltd
Income Statement
Earnings Waterfall
PharmaResearch Co Ltd
PharmaResearch Co Ltd
|
Revenue
|
317B
KRW
|
|
Cost of Revenue
|
-92B
KRW
|
|
Gross Profit
|
225B
KRW
|
|
Operating Expenses
|
-115.4B
KRW
|
|
Operating Income
|
109.6B
KRW
|
|
Other Expenses
|
-20.9B
KRW
|
|
Net Income
|
88.8B
KRW
|
Income Statement
PharmaResearch Co Ltd
PharmaResearch Co Ltd
Currency: KRW
| Dec-2014 | Mar-2015 | Jun-2015 | Sep-2015 | Dec-2015 | Mar-2016 | Jun-2016 | Sep-2016 | Dec-2016 | Mar-2017 | Jun-2017 | Sep-2017 | Dec-2017 | Mar-2018 | Jun-2018 | Sep-2018 | Dec-2018 | Mar-2019 | Jun-2019 | Sep-2019 | Dec-2019 | Mar-2020 | Jun-2020 | Sep-2020 | Dec-2020 | Mar-2021 | Jun-2021 | Sep-2021 | Dec-2021 | Mar-2022 | Jun-2022 | Sep-2022 | Dec-2022 | Mar-2023 | Jun-2023 | Sep-2023 | Dec-2023 | Mar-2024 | Jun-2024 | Sep-2024 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | |||||||||||||||||||||||||||||||||||||||||
| Revenue |
24 765
N/A
|
28 237
+14%
|
31 577
+12%
|
34 543
+9%
|
37 455
+8%
|
40 854
+9%
|
43 810
+7%
|
45 094
+3%
|
45 953
+2%
|
46 580
+1%
|
47 240
+1%
|
50 614
+7%
|
54 470
+8%
|
56 518
+4%
|
60 777
+8%
|
61 865
+2%
|
64 281
+4%
|
70 242
+9%
|
73 324
+4%
|
77 416
+6%
|
83 872
+8%
|
84 091
+0%
|
91 747
+9%
|
101 283
+10%
|
108 746
+7%
|
122 609
+13%
|
133 706
+9%
|
143 282
+7%
|
154 083
+8%
|
164 813
+7%
|
175 719
+7%
|
183 191
+4%
|
194 759
+6%
|
204 932
+5%
|
222 030
+8%
|
244 661
+10%
|
261 011
+7%
|
280 285
+7%
|
296 594
+6%
|
316 997
+7%
|
|
| Gross Profit | |||||||||||||||||||||||||||||||||||||||||
| Cost of Revenue |
(6 555)
|
(7 830)
|
(9 611)
|
(10 579)
|
(11 687)
|
(12 644)
|
(12 999)
|
(14 187)
|
(15 116)
|
(15 612)
|
(16 131)
|
(17 038)
|
(18 405)
|
(19 216)
|
(21 862)
|
(23 409)
|
(26 064)
|
(28 623)
|
(30 954)
|
(33 140)
|
(33 766)
|
(33 603)
|
(34 271)
|
(35 024)
|
(35 850)
|
(38 538)
|
(40 183)
|
(42 495)
|
(45 750)
|
(49 113)
|
(51 440)
|
(52 202)
|
(53 246)
|
(54 915)
|
(58 063)
|
(63 915)
|
(70 753)
|
(78 668)
|
(85 590)
|
(92 009)
|
|
| Gross Profit |
18 210
N/A
|
20 408
+12%
|
21 967
+8%
|
23 965
+9%
|
25 768
+8%
|
28 210
+9%
|
30 811
+9%
|
30 907
+0%
|
30 837
0%
|
30 968
+0%
|
31 109
+0%
|
33 577
+8%
|
36 065
+7%
|
37 303
+3%
|
38 916
+4%
|
38 456
-1%
|
38 217
-1%
|
41 620
+9%
|
42 371
+2%
|
44 277
+4%
|
50 106
+13%
|
50 488
+1%
|
57 476
+14%
|
66 258
+15%
|
72 896
+10%
|
84 070
+15%
|
93 522
+11%
|
100 787
+8%
|
108 333
+7%
|
115 701
+7%
|
124 280
+7%
|
130 989
+5%
|
141 513
+8%
|
150 018
+6%
|
163 967
+9%
|
180 746
+10%
|
190 258
+5%
|
201 617
+6%
|
211 004
+5%
|
224 988
+7%
|
|
| Operating Income | |||||||||||||||||||||||||||||||||||||||||
| Operating Expenses |
(6 796)
|
(7 045)
|
(7 944)
|
(8 201)
|
(9 674)
|
(12 377)
|
(13 960)
|
(14 210)
|
(16 732)
|
(15 272)
|
(15 728)
|
(17 083)
|
(21 222)
|
(24 021)
|
(26 780)
|
(30 758)
|
(29 512)
|
(33 589)
|
(30 956)
|
(30 620)
|
(31 044)
|
(31 783)
|
(34 868)
|
(37 797)
|
(39 470)
|
(44 155)
|
(47 738)
|
(50 830)
|
(55 844)
|
(61 109)
|
(66 208)
|
(70 050)
|
(75 597)
|
(83 708)
|
(91 402)
|
(97 204)
|
(98 001)
|
(106 550)
|
(108 823)
|
(115 379)
|
|
| Selling, General & Administrative |
(4 671)
|
(4 817)
|
(5 883)
|
(6 252)
|
(7 439)
|
(9 862)
|
(10 874)
|
(11 369)
|
(12 844)
|
(11 302)
|
(10 914)
|
(11 366)
|
(16 127)
|
(17 283)
|
(20 435)
|
(23 398)
|
(21 213)
|
(22 809)
|
(21 449)
|
(20 827)
|
(20 536)
|
(21 379)
|
(24 260)
|
(26 711)
|
(28 535)
|
(31 034)
|
(33 691)
|
(36 760)
|
(42 762)
|
(46 882)
|
(51 123)
|
(53 941)
|
(59 651)
|
(61 367)
|
(67 182)
|
(71 841)
|
(75 095)
|
(79 359)
|
(80 270)
|
(84 434)
|
|
| Research & Development |
(1 899)
|
(1 624)
|
(1 615)
|
(1 569)
|
(1 763)
|
(2 013)
|
(2 578)
|
(2 309)
|
(3 378)
|
(3 447)
|
(4 269)
|
(5 150)
|
(4 497)
|
(5 206)
|
(4 529)
|
(4 379)
|
(4 043)
|
(4 177)
|
(4 368)
|
(4 824)
|
(5 614)
|
(5 569)
|
(5 386)
|
(5 673)
|
(5 543)
|
(6 167)
|
(6 793)
|
(6 581)
|
(6 738)
|
(7 002)
|
(7 578)
|
(8 305)
|
(8 702)
|
(9 706)
|
(11 481)
|
(12 506)
|
(15 030)
|
(16 189)
|
(17 727)
|
(19 946)
|
|
| Depreciation & Amortization |
(226)
|
(575)
|
(417)
|
(351)
|
(471)
|
(497)
|
(504)
|
(529)
|
(510)
|
(523)
|
(543)
|
(566)
|
(597)
|
(649)
|
(1 815)
|
(2 980)
|
(4 257)
|
(5 570)
|
(5 143)
|
(4 973)
|
(4 894)
|
(4 837)
|
(5 224)
|
(5 414)
|
(5 392)
|
(5 704)
|
(6 009)
|
(6 244)
|
(6 344)
|
(6 385)
|
(6 715)
|
(7 013)
|
(7 384)
|
(7 711)
|
(7 767)
|
(7 885)
|
(8 003)
|
(8 171)
|
(8 222)
|
(8 394)
|
|
| Other Operating Expenses |
0
|
(29)
|
(29)
|
(29)
|
0
|
(5)
|
(4)
|
(3)
|
0
|
0
|
0
|
0
|
0
|
(883)
|
0
|
0
|
0
|
(1 033)
|
4
|
4
|
0
|
0
|
0
|
0
|
0
|
(1 250)
|
(1 245)
|
(1 245)
|
0
|
(840)
|
(792)
|
(792)
|
140
|
(4 924)
|
(4 972)
|
(4 972)
|
128
|
(2 831)
|
(2 605)
|
(2 605)
|
|
| Operating Income |
11 414
N/A
|
13 361
+17%
|
14 022
+5%
|
15 763
+12%
|
16 094
+2%
|
15 833
-2%
|
16 850
+6%
|
16 696
-1%
|
14 105
-16%
|
15 695
+11%
|
15 382
-2%
|
16 494
+7%
|
14 843
-10%
|
13 283
-11%
|
12 136
-9%
|
7 699
-37%
|
8 705
+13%
|
8 030
-8%
|
11 414
+42%
|
13 656
+20%
|
19 062
+40%
|
18 706
-2%
|
22 609
+21%
|
28 463
+26%
|
33 426
+17%
|
39 917
+19%
|
45 786
+15%
|
49 958
+9%
|
52 489
+5%
|
54 592
+4%
|
58 071
+6%
|
60 939
+5%
|
65 916
+8%
|
66 309
+1%
|
72 565
+9%
|
83 541
+15%
|
92 258
+10%
|
95 067
+3%
|
102 181
+7%
|
109 609
+7%
|
|
| Pre-Tax Income | |||||||||||||||||||||||||||||||||||||||||
| Interest Income Expense |
(304)
|
(330)
|
(453)
|
(132)
|
168
|
1 813
|
3 455
|
4 165
|
3 308
|
2 250
|
1 740
|
1 319
|
1 861
|
2 100
|
3 204
|
2 874
|
650
|
1 232
|
(1 359)
|
(918)
|
73
|
(154)
|
(81)
|
(866)
|
3 382
|
3 146
|
3 848
|
5 993
|
4 030
|
2 555
|
(2 426)
|
(1 314)
|
(6 668)
|
(3 937)
|
960
|
4 686
|
12 355
|
7 014
|
13 792
|
4 002
|
|
| Non-Reccuring Items |
(29)
|
0
|
0
|
0
|
(3)
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
(881)
|
0
|
(1 917)
|
(1 917)
|
(868)
|
0
|
0
|
0
|
67
|
0
|
(6)
|
(6)
|
(1 251)
|
0
|
0
|
0
|
(840)
|
0
|
0
|
0
|
(5 111)
|
0
|
0
|
0
|
(3 120)
|
0
|
0
|
0
|
|
| Gain/Loss on Disposition of Assets |
(16)
|
(5)
|
(5)
|
(5)
|
(1)
|
(4)
|
(7)
|
(49)
|
(60)
|
(87)
|
(89)
|
(59)
|
(84)
|
0
|
(187)
|
(396)
|
(495)
|
0
|
(513)
|
(473)
|
(325)
|
0
|
0
|
(231)
|
(363)
|
0
|
0
|
0
|
230
|
254
|
290
|
245
|
(114)
|
(88)
|
(127)
|
(83)
|
36
|
(6)
|
(1)
|
(1)
|
|
| Total Other Income |
25
|
21
|
(49)
|
(42)
|
(73)
|
(95)
|
(92)
|
(92)
|
(28)
|
(17)
|
(327)
|
(328)
|
(344)
|
(405)
|
(607)
|
(708)
|
6 373
|
5 430
|
6 481
|
6 662
|
(348)
|
(277)
|
4 443
|
4 432
|
4 343
|
4 256
|
(290)
|
88
|
124
|
22
|
64
|
2
|
25
|
71
|
(643)
|
(561)
|
(825)
|
(938)
|
(155)
|
(1 059)
|
|
| Pre-Tax Income |
11 091
N/A
|
13 047
+18%
|
13 516
+4%
|
15 585
+15%
|
16 185
+4%
|
17 547
+8%
|
20 205
+15%
|
20 719
+3%
|
17 325
-16%
|
17 842
+3%
|
16 706
-6%
|
17 426
+4%
|
15 396
-12%
|
14 978
-3%
|
12 628
-16%
|
7 551
-40%
|
14 364
+90%
|
14 692
+2%
|
16 023
+9%
|
18 927
+18%
|
18 529
-2%
|
18 275
-1%
|
26 965
+48%
|
31 791
+18%
|
39 537
+24%
|
47 319
+20%
|
49 345
+4%
|
56 038
+14%
|
56 033
0%
|
57 423
+2%
|
55 999
-2%
|
59 872
+7%
|
54 048
-10%
|
62 356
+15%
|
72 754
+17%
|
87 583
+20%
|
100 705
+15%
|
101 137
+0%
|
115 817
+15%
|
112 551
-3%
|
|
| Net Income | |||||||||||||||||||||||||||||||||||||||||
| Tax Provision |
(2 254)
|
(2 633)
|
(2 884)
|
(3 277)
|
(3 308)
|
(3 553)
|
(3 830)
|
(4 056)
|
(3 498)
|
(3 613)
|
(3 478)
|
(3 219)
|
(2 879)
|
(2 795)
|
(2 955)
|
(2 840)
|
(3 099)
|
(3 285)
|
(2 726)
|
(2 697)
|
(3 678)
|
(3 604)
|
(5 787)
|
(6 579)
|
(7 085)
|
(6 697)
|
(6 511)
|
(7 152)
|
(9 210)
|
(13 088)
|
(13 642)
|
(14 193)
|
(10 614)
|
(10 446)
|
(15 440)
|
(18 683)
|
(23 440)
|
(23 895)
|
(25 039)
|
(24 456)
|
|
| Income from Continuing Operations |
8 838
|
10 414
|
10 631
|
12 307
|
12 878
|
13 993
|
16 375
|
16 664
|
13 827
|
14 229
|
13 228
|
14 206
|
12 517
|
12 183
|
9 673
|
4 711
|
11 265
|
11 406
|
13 296
|
16 229
|
14 851
|
14 671
|
21 178
|
25 212
|
32 452
|
40 623
|
42 834
|
48 886
|
46 824
|
44 335
|
42 357
|
45 680
|
43 434
|
51 910
|
57 314
|
68 900
|
77 265
|
77 243
|
90 778
|
88 094
|
|
| Income to Minority Interest |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
60
|
82
|
149
|
245
|
317
|
439
|
397
|
1 463
|
2 203
|
3 143
|
3 904
|
3 087
|
2 831
|
1 817
|
1 736
|
1 930
|
1 790
|
322
|
(470)
|
(1 300)
|
(1 775)
|
(135)
|
(583)
|
9
|
821
|
(2 857)
|
(2 946)
|
(1 699)
|
(3 998)
|
(713)
|
(1 151)
|
(34)
|
663
|
|
| Net Income (Common) |
8 836
N/A
|
10 413
+18%
|
10 629
+2%
|
12 305
+16%
|
12 878
+5%
|
13 993
+9%
|
16 375
+17%
|
16 725
+2%
|
13 909
-17%
|
14 378
+3%
|
13 473
-6%
|
14 523
+8%
|
12 956
-11%
|
12 580
-3%
|
11 135
-11%
|
6 914
-38%
|
14 408
+108%
|
15 311
+6%
|
16 385
+7%
|
19 061
+16%
|
16 667
-13%
|
16 408
-2%
|
23 109
+41%
|
27 003
+17%
|
32 774
+21%
|
40 152
+23%
|
41 533
+3%
|
47 109
+13%
|
46 689
-1%
|
43 752
-6%
|
42 366
-3%
|
46 501
+10%
|
40 577
-13%
|
48 964
+21%
|
55 615
+14%
|
64 902
+17%
|
76 551
+18%
|
76 092
-1%
|
90 744
+19%
|
88 757
-2%
|
|
| EPS (Diluted) |
1 262.28
N/A
|
1 487.57
+18%
|
1 518.42
+2%
|
1 757.85
+16%
|
1 609.75
-8%
|
1 554.77
-3%
|
1 819.44
+17%
|
1 858.33
+2%
|
1 545.44
-17%
|
1 597.55
+3%
|
1 497
-6%
|
1 613.66
+8%
|
1 439.55
-11%
|
1 258
-13%
|
1 237.22
-2%
|
768.22
-38%
|
1 440.8
+88%
|
1 531.1
+6%
|
1 820.55
+19%
|
2 117.88
+16%
|
1 851.88
-13%
|
1 823.11
-2%
|
2 310.9
+27%
|
2 700.3
+17%
|
3 277.4
+21%
|
4 063.45
+24%
|
4 163.31
+2%
|
4 722.28
+13%
|
4 644.41
-2%
|
4 149.42
-11%
|
4 018
-3%
|
4 410.17
+10%
|
3 848.31
-13%
|
4 638.18
+21%
|
5 236.01
+13%
|
6 155.34
+18%
|
7 249.68
+18%
|
7 205.61
-1%
|
8 593.11
+19%
|
8 404.95
-2%
|
|
Switch to:
Switch to:
See Also
Discover More
You don't have any saved screeners yet
